Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:BCRX
Tag: NASDAQ:BCRX
Analyst Activity – HC Wainwright Reiterates Buy on BioCryst Pharmaceuticals (NASDAQ:BCRX)
ME Staff
-
January 23, 2018
0
BioCryst Pharmaceuticals,Inc. (NASDAQ:BCRX) Files An 8-K Entry into a Material Definitive...
ME Staff 8-k
-
January 22, 2018
0
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Files An 8-K Regulation FD Disclosure
ME Staff 8-k
-
January 5, 2018
0
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Files An 8-K Results of Operations and...
ME Staff 8-k
-
November 7, 2017
0
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) reported earnings of ($0.21) per share missing...
ME Staff
-
August 7, 2017
0
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Files An 8-K Results of Operations and...
ME Staff 8-k
-
August 7, 2017
0
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Files An 8-K Other Events
ME Staff 8-k
-
August 2, 2017
0
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
May 30, 2017
0
Biotech Movers: Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) and BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
-
May 26, 2017
0
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Files An 8-K Regulation FD Disclosure
ME Staff 8-k
-
May 25, 2017
0
1
...
3
4
5
Page 4 of 5
